Section 152.34 — Health Care Facilities.
152.34 HEALTH CARE FACILITIES. (a) Health care facilities licensed under chapter 144A, hospice providers licensed under chapter 144A, boarding care homes or supervised living facilities licensed under section 144.50, assisted living facilities, facilities owned, controlled, managed, or under common control with hospitals licensed under chapter 144, and other health facilities licensed by the commissioner of […]
Section 152.35 — Fees; Deposit Of Revenue.
152.35 FEES; DEPOSIT OF REVENUE. (a) The commissioner shall collect an enrollment fee of $200 from patients enrolled under this section. If the patient provides evidence of receiving Social Security disability insurance (SSDI), Supplemental Security Income (SSI), veterans disability, or railroad disability payments, or being enrolled in medical assistance or MinnesotaCare, then the fee shall […]
Section 152.36 — Impact Assessment Of Medical Cannabis Therapeutic Research.
152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH. Subdivision 1. Task force on medical cannabis therapeutic research. (a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members: (1) two members of the house of […]
Section 152.37 — Financial Examinations; Pricing Reviews.
152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS. Subdivision 1. Financial records. A medical cannabis manufacturer shall maintain detailed financial records in a manner and format approved by the commissioner, and shall keep all records updated and accessible to the commissioner when requested. Subd. 2. Certified annual audit. A medical cannabis manufacturer shall submit the results of an […]
Section 152.27 — Patient Registry Program Established.
152.27 PATIENT REGISTRY PROGRAM ESTABLISHED. Subdivision 1. Patient registry program; establishment. (a) The commissioner shall establish a patient registry program to evaluate data on patient demographics, effective treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting on the benefits, risks, and outcomes regarding patients with a qualifying medical condition engaged in the […]
Section 152.28 — Health Care Practitioner Duties.
152.28 HEALTH CARE PRACTITIONER DUTIES. Subdivision 1. Health care practitioner duties. (a) Prior to a patient’s enrollment in the registry program, a health care practitioner shall: (1) determine, in the health care practitioner’s medical judgment, whether a patient suffers from a qualifying medical condition, and, if so determined, provide the patient with a certification of […]
Section 152.29 — Manufacturer Of Medical Cannabis Duties.
152.29 MANUFACTURER OF MEDICAL CANNABIS DUTIES. Subdivision 1. Manufacturer; requirements. (a) A manufacturer may operate eight distribution facilities, which may include the manufacturer’s single location for cultivation, harvesting, manufacturing, packaging, and processing but is not required to include that location. The commissioner shall designate the geographical service areas to be served by each manufacturer based […]
Section 152.30 — Patient Duties.
152.30 PATIENT DUTIES. (a) A patient shall apply to the commissioner for enrollment in the registry program by submitting an application as required in section 152.27 and an annual registration fee as determined under section 152.35. (b) As a condition of continued enrollment, patients shall agree to: (1) continue to receive regularly scheduled treatment for […]
Section 152.31 — Data Practices.
152.31 DATA PRACTICES. (a) Government data in patient files maintained by the commissioner and the health care practitioner, and data submitted to or by a medical cannabis manufacturer, are private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in section 13.02, subdivision 9, but may be used for […]
Section 152.32 — Protections For Registry Program Participation.
152.32 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPATION. Subdivision 1. Presumption. (a) There is a presumption that a patient enrolled in the registry program under sections 152.22 to 152.37 is engaged in the authorized use of medical cannabis. (b) The presumption may be rebutted by evidence that conduct related to use of medical cannabis was not for […]